(MedPage Today) -- A topical formulation of tamoxifen matched oral therapy for antiproliferative activity in ductal carcinoma in situ with fewer potentially troublesome effects on endocrine and coagulation parameters, a small randomized trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment